Advertising representation for cosmetics and quasi-drugs

Regarding the efficacies for cosmetics, 55 indications applicable to cosmetics were stipulated in the 2000 Notify of "Revision of the Scope of Indications for Cosmetics." In 2011, an additional indication was added to the indication of " Reduces the appearance of fine lines caused by dryness." Yet the scope of efficacy claims approved in Japan is still narrower than in Europe, which hinders foreign-made cosmetics based on the latest research and technology from entering the Japanese market. The Japanese cosmetics industry is currently studying the efficacy claim of "prevention of ultraviolet ray-derived photo-ageing" which may lead to a further expansion. In recent years, the promotion of self-care and self-medication is required for the realisation of healthy long-lived social. Daily care by cosmetics and quasi-drugs, such as wet care for atopic skin and use of suntan products to prevent skin cancer, plays an important role in maintaining health and improving the quality of life, and contributing to disease prevention and thereby curbing medical costs. Current advertising regulations, however, do not allow the importance of such care to be promoted. It is also stated that "illustration of experience and presentation of indications for indications" should not be made because it is not objectively underpinned and there is a risk that consumers may be misled about the efficacy, etc. or safety. This is an important factor and often used by the consumer when choosing particular product. Furthermore, given the continuing trend of growth in the number of mail order users, the opinions of those experienced in use have become increasingly important information for consumers. If it is possible to post user experience statements in the advertising of cosmetics, it will be possible to respond to the diversification of consumer demand and to communicate a wide range of information to consumers.